BERT - A phase I/II trial to evaluate the safety, feasibility and efficacy of the addition of Temsirolimus (Torisel™) to a regimen of Bendamustine and Rituximab for the treatment of patients with follicular lymphoma or mantle cell lymphoma in first to third relapse
Laufzeit: 01.01.2009 - 31.12.2017